Litcius/Paper detail

Discovery of 4’-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation

Yue Wu, Jinhui Shi, Guanghao Zhu, Yuan Xiong, Jia-Hao Gong, Huizhen Wei, Zhao-Bin Guo, Ziru Dai, Xiao-Bo Sun, Guang‐Bo Ge

2023European Journal of Medicinal Chemistry13 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryChalconeIC50StereochemistryDocking (animal)TrifluoromethylEnzymeAntagonistStructure–activity relationshipPharmacologyBiochemistryIn vitroReceptorAlkylNursingOrganic chemistryMedicinePharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsInflammatory mediators and NSAID effects
Discovery of 4’-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation | Litcius